US Thyroid Cancer Market: Trends and Opportunities (2015 – 2019) – New Report by Daedal Research

DELHI, India - April 6, 2015 - PRLog -- The report analyzes in detail the segments of Thyroid Cancer Market that includes Thyroid Cancer Diagnostics Surgeries, Thyroid Histopathology Market, Thyroid Cancer Secondary Surgery and Thyroid Cancer Hormone Replacement Market. The report assesses thyroid cancer types, stages and incidence rate of the disease and also discusses the factors that will result in the demand and growth of the market. Further, companies like Veracyte Inc., Mylan Inc., Forest Laboratories, Abott Laboratories and Oxigene Inc. are profiled in the report.

Product Coverage

Thyroid Cancer Diagnostic Surgeries
Thyroid Cancer Histopathology Market
Thyroid Cancer Secondary Surgery
Thyroid Cancer Hormone Replacement

FNA biopsies Company Coverage

Veracyte Inc.
Mylan Inc.
Forest Laboratories
Abott Laboratories
Oxigene Inc.

Executive Summary

Thyroid cancer, a type of malignant cancer, initiate from follicular and par follicular thyroid cells. The most effective treatment of thyroid cancer is surgical removal of thyroid gland followed by radioactive ablation and thyroid stimulating hormone (TSH) suppression therapy. Chemotherapy is also used in cases of metastasis and progressive stage of thyroid cancer. Thyroid cancer market is accelerating in the United States since 2010 and it is a disease which is fast on the rise. Incidence has more than doubled since the early 1970s, and for women, it is the cancer with the fastest-growing number of new cases.

On the back of high incidence of thyroid cancer, it is anticipated that the thyroid cancer market in US will observe impressive double digit growth in next five years. The thyroid cancer diagnosis market is segmented into diagnostic surgeries, histopathology, secondary surgery and annual new patient hormone replacement therapy. The diagnostic technology has improved since 2011 and with use of Afirma GEC test and Afirma FNA; the detection of even minor nodules has become possible.

The report titled “US Thyroid Cancer Market: Trends and Opportunities (2015-2019)” provides an insight into overall thyroid cancer sector of United States of America. The report includes detailed information on market size, installed base and geographical segmentation of overall sector. The market segmentation on basis of thyroid cancer type, stage and incidence rate is also given in detail. It also discusses key growth drivers, challenges and trends of the market. Further, companies like Veracyte Inc., Mylan Inc., Forest Laboratories, Abott Laboratories and Oxigene Inc. are profiled in the report.

Table of Contents:


1. Executive Summary

2. United States Thyroid Cancer Market: An Introduction

2.1 Cancer Cells

2.2 Types of Thyroid Cancer

2.3 Diagnosis

2.4 Staging

2.5 Treatment

2.5.1 Surgery

2.5.2 Radioactive Iodine Therapy

2.5.3 External Radiation Therapy

2.6 Thyroid Cancer Drugs

3. US Thyroid Cancer Market: Sizing and Growth

3.1 U.S Thyroid Cancer Market: 2010-2014

3.2 U.S Thyroid Cancer Market: 2015-2019

4. US Thyroid Cancer Market Segmentation

4.1 U.S Thyroid Cancer Diagnostic Surgeries Market

4.1.1 U.S Thyroid Cancer Diagnostic Surgeries Market: 2010-2014

4.1.2 U.S Thyroid Cancer Diagnostic Surgeries Market: 2015-2019

4.2 Thyroid Cancer Histopathology Market

4.2.1 Thyroid Cancer Histopathology Market: 2010-2014

4.2.2 Thyroid Cancer Histopathology Market: 2015-2019

4.3 Thyroid Cancer Secondary Surgery Market

4.3.1 U.S Thyroid Cancer Secondary Surgery Market: 2010-2014

4.3.2 U.S Thyroid Cancer Secondary Surgery Market: 2015-2019

4.4 Thyroid Cancer Hormone Replacement Market

4.4.1 U.S Thyroid Cancer Hormone Replacement Market: 2010-2014

4.4.2 U.S Thyroid Cancer Hormone Replacement Market: 2015-2019

4.5 U.S thyroid cancer market: By Cancer Type

4.6 U.S thyroid cancer market: Cases by Cancer Stage

5. U.S Thyroid Cancer Diagnosis Market: By FNA volume

5.1 U.S Thyroid Cancer Diagnosis Market- FNA Volume: 2010-2014

5.2 U.S Thyroid Cancer Diagnosis Market- FNA Volume: 2015-2019

6. Market Dynamics: US Thyroid Cancer Diagnosis Market

6.1 Growth Drivers

6.1.1 Fast growing cancer market in the US

6.1.2 Growing Middle Age population

6.1.3 Escalating Healthcare Expenditure in the US

6.1.4 Economic Growth

6.2 Challenges

6.2.1 Risk of surgery

6.2.2 Regulatory issues

6.3 Trends

6.3.1 Rate of survival after diagnosis

4.3.2 Provides cost savings to healthcare suppliers and patients

6.3.3 Early approval of Lenvima presents additional growth opportunities

6.3.4 Launch of Affirma test and GEC

6.3.5 Thyroid Nodules More Common in Women

7. Competitive Landscape: U.S Thyroid Cancer Diagnosis Market

8. Company Profiles: U.S Thyroid Cancer Diagnosis Market

8.1 Veracyte Inc.

8.1.1 Business Overview

8.1.2 Financial Overview

8.1.3 Business strategies

8.2 Oxigene Inc.

8.2.1 Business Overview

8.2.2 Financial Overview

8.2.3 Business strategies

8.3 Forest Laboratories

8.3.1 Business Overview

8.3.2 Financial Overview

8.3.3 Business strategies

8.4 Mylan Inc.

8.4.1 Business Overview

8.4.2 Financial overview

8.4.3 Business strategies

8.5 Abbott Laboratories

8.5.1 Business Overview

8.5.2 Financial Overview

8.5.3 Business Strategy

List of Figures:


Figure 1: U.S Thyroid Cancer Market: 2010-2014
Figure 2: U.S Thyroid Cancer Market Segmentation: 2014
Figure 3: U.S Thyroid Cancer Market: 2015-2019
Figure 4: U.S Thyroid Cancer Diagnostic surgeries: 2010-2014- US$ Million
Figure 5: U.S Thyroid Cancer Diagnostic surgeries: 2015-2019- US$ Billion
Figure 6: U.S Thyroid Cancer Histopathology Market: 2010-2014-US$ Million
Figure 7: U.S Thyroid Cancer Histopathology Market: 2015-2019-US$ Million
Figure 8: U.S Thyroid Cancer Secondary Surgery Market: 2010-2014-US$ Million
Figure 9: U.S Thyroid Cancer Secondary Surgery Market: 2015-2019-US$ Million
Figure 10: U.S Thyroid Cancer Hormone Replacement Market: 2010-2014-US$ Million
Figure 11: U.S Thyroid Cancer Hormone Replacement Market: 2015-2019-US$ Million
Figure 12: Incidence of Thyroid Cancer Types: 2013
Figure 13: Percent of Cases by Stage of Cancer (US Patients, 2010-2013)
Figure 14: U.S Thyroid Cancer Diagnosis Market- FNA Volume: 2010-2014
Figure 15: Cancer Type Result From FNA in Percentage
Figure 136 U.S Thyroid Cancer Diagnosis Market- FNA Volume: 2015-2019
Figure 17: Increasing Thyroid Cancer Incidence: 2009-2013

Table1: TNM Classification for Differentiated Thyroid Cancer
Table 2: FDA Approved drugs for thyroid cancer treatment
Table 3: Investigational agents for thyroid cancer
Table 4: 5-Year and 10-Year Surviaval Rate by cancer type
Table 5: U.S Major Players of Thyroid Cancer Market

For further details, kindly visit :

http://www.daedal-research.com/us-thyroid-cancer-market-trends-and-opportunities-2015-2019

Rajeev Kumar

(Business Development Manager)

Address:  36 SFS Flats

Paschim Vihar

New Delhi-110063

Mobile: +91-8743975789

Tel: +91-120-4553017

Mail ID - info@daedal-research.com

Daedal Research is a research and consulting firm specialized in providing research reports and customized business research and analysis. For more Information:

http://www.daedal-research.com